AMWD vs JAZZ · P/E 8.7, rev $1.71B vs P/E 1988, rev $2.28B
American Woodmark Corporation (AMWD) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
American Woodmark Corporation (AMWD) is a furnishings, fixtures & appliances company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported AMWD revenue for 2025-04-30 was $1.71B. Net income was $99.5M. Revenue was down 7.5% from 2024-04-30 to 2025-04-30. AMWD currently screens at market cap $836.0M and trailing P/E 8.7.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
AMWD currently screens at market cap $836.0M and trailing P/E 8.7. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the AMWD and JAZZ stock pages for the full models.
Not investment advice.